In cancer cells, aberrant phosphorylation events may result in the accumulation of phosphorylated RXRα (p-RXRα), which can escape degradation mechanisms, leading to an excess of non-functional RXR (Yoshimura et al., 2007). Here, RXRA is linked to cancer.